Back to results
US 8,524,733 B2Granted
Benzoquinoline inhibitors of vesicular monoamine transporter 2
AssigneeAuspex Pharmaceuticals, Inc.
InventorsThomas G. Gant, Manoucherhr M. Shahbaz
Life of this patent
Estimating the term…
Abstract
The present invention relates to new benzoquinoline inhibitors of vesicular monoamine transporter 2 (VMAT2), pharmaceutical compositions thereof, and methods of use thereof.
Claims3
A compound having the structural formula:
- or a salt thereof, wherein each position represented as D has deuterium enrichment of no less than about 90%.
Dependencies are inferred from the claim text.